Short- and long-term outcomes of 34 patients with drug-induced hypersensitivity syndrome in a single institution

Journal of the American Academy of Dermatology

Volumn 68, Issue 5, 2013, Pages 721-728

  Ushigome, Yukiko ^a   Kano, Yoko ^a   Ishida, Tadashi ^a   Hirahara, Kazuhisa ^a   Shiohara, Tetsuo ^a  

^a KYORIN UNIVERSITY   (Japan)

Author keywords

complication; corticosteroid; drug reaction; drug reaction with eosinophilia and systemic symptoms; drug induced hypersensitivity syndrome; herpesvirus; outcome; treatment; viral reactivation

Indexed keywords

AUTOANTIBODY; CORTICOSTEROID; IMMUNOGLOBULIN; INFUSION FLUID;

ADULT; ARTICLE; AUTOIMMUNE THYROIDITIS; BACTERIAL INFECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DRESS SYNDROME; DRUG DOSE REDUCTION; FEMALE; HERPES VIRUS INFECTION; HUMAN; HUMAN TISSUE; LUPUS ERYTHEMATOSUS; MALE; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT; PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANTIBODIES, VIRAL; AUTOANTIBODIES; DRUG ERUPTIONS; DRUG HYPERSENSITIVITY; EOSINOPHILIA; FEMALE; HERPESVIRUS 6, HUMAN; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; ROSEOLOVIRUS INFECTIONS; SYNDROME; THYROIDITIS, AUTOIMMUNE; TREATMENT OUTCOME;

EID: 84876415346     PISSN: 01909622     EISSN: 10976787     Source Type: Journal    
DOI: 10.1016/j.jaad.2012.10.017     Document Type: Article

References (27)

1. V. Descamps, F. Bouscarat, S. Laglenne, E. Aslangul, B. Veber, and D. Descamps Human herpesvirus 6 infection associated with anticonvulsant hypersensitivity syndrome and reactive hemophagocytic syndrome Br J Dermatol 137 1997 605 608
2. Y. Suzuki, R. Inagi, T. Aono, K. Yamanishi, and T. Shiohara Human herpesvirus 6 infection as a risk factor for the development of severe drug-induced hypersensitivity syndrome Arch Dermatol 134 1998 1108 1112
3. M. Tohyama, Y. Yahata, M. Yasukawa, R. Inagi, Y. Urano, and K. Yamanishi Severe hypersensitivity syndrome due to sulfasalazine associated with reactivation of human herpesvirus 6 Arch Dermatol 134 1998 1113 1117
4. Y. Kano, K. Hirahara, K. Sakuma, and T. Shiohara Several herpesviruses can reactivate in a severe drug-induced multiorgan reaction in the same sequential order as in graft-versus-host disease Br J Dermatol 155 2006 301 306
5. M. Seishima, S. Yamanaka, T. Fujisawa, M. Tohyama, and K. Hashimoto Reactivation of human herpesvirus (HHV) family members other than HHV-6 in drug-induced hypersensitivity syndrome Br J Dermatol 115 2006 344 349
6. D. Picard, B. Janela, V. Descamps, M. D'Incan, P. Courville, and S. Jacquot Drug reaction with eosinophilia and systemic symptoms (DRESS): a multiorgan antiviral T cell response Sci Transl Med 2 2010 45ra62
7. Y. Kano, K. Sakuma, and T. Shiohara Sclerodermoid graft-versus-host disease-like lesions occurring after drug-induced hypersensitivity syndrome Br J Dermatol 156 2007 1061 1063
8. N. Aota, K. Hirahara, Y. Kano, T. Fukuoka, and T. Shiohara Systemic lupus erythematosus presenting with Kikuchi-Fujimoto's disease as a long-term sequel of drug-induced hypersensitivity syndrome; a possible role of Epstein-Barr virus reactivation Dermatology 218 2009 275 277
9. R.J. Brown, K.I. Rother, H. Artman, M.G. Mercurio, R. Wanq, and R.J. Looney Minocycline-induced drug hypersensitivity syndrome followed by multiple autoimmune sequelae Arch Dermatol 145 2009 63 66
10. M. Eshki, L. Allanore, P. Musette, B. Milipied, A. Grange, and J.C. Guillaume Twelve-year analysis of severe cases of drug reaction with eosinophilia and systemic symptoms: a cause of unpredictable multiorgan failure Arch Dermatol 145 2009 67 72
11. N. Sekine, T. Motokura, T. Oki, Y. Umeda, N. Sasaki, and M. Hayashi Rapid loss of insulin secretion in a patient with fulminant type 1 diabetes mellitus and carbamazepine hypersensitivity syndrome JAMA 285 2001 1153 1154
12. C.C. Chiou, W.H. Chung, S.I. Hung, L.C. Yang, and H.S. Hong Fulminant type 1 diabetes mellitus caused by drug hypersensitivity syndrome with human herpesvirus 6 infection J Am Acad Dermatol 54 Suppl 2006 S14 S17
13. C.C. Chiou, L.C. Yang, S.I. Hung, Y.C. Chang, T.T. Kuo, and H.C. Ho Clinicopathological features and prognosis of drug rash with eosinophilia and systemic symptoms: a study of 30 cases in Taiwan J Eur Acad Dermatol Venereol 22 2008 1044 1049
14. P. Cacoub, P. Musette, V. Descamps, O. Meyer, C. Speirs, and L. Finzi The DRESS syndrome: a literature review Am J Med 124 2011 588 597
15. T. Shiohara, M. Iijima, Z. Ikezawa, and K. Hashimoto The diagnosis of a DRESS syndrome has been sufficiently established on the basis of typical clinical features and viral reactivations Br J Dermatol 156 2007 1083 1084
16. S.H. Kardaun, A. Sidoroff, L. Valeyrie-Allanore, S. Halevy, B.B. Davidovici, and M. Mockenhaupt Variability in the clinical pattern of cutaneous side-effects of drugs with systemic symptoms: does a DRESS syndrome really exist? Br J Dermatol 156 2007 609 611
17. Y. Kano, C. Horie, M. Inaoka, T. Ishida, and T. Shiohara Herpes zoster in patients with drug-induced hypersensitivity syndrome/DRESS Acta Dermatol Venereol 92 2012 206 207
18. Y. Asano, H. Kagawa, Y. Kano, and T. Shiohara Cytomegalovirus disease during severe drug eruptions: report of 2 cases and retrospective study of 18 patients with drug-induced hypersensitivity syndrome Arch Dermatol 145 2009 1030 1036
19. K. Sakuma, Y. Kano, M. Fukuhara, and T. Shiohara Syndrome of inappropriate secretion of antidiuretic hormone associated with limbic encephalitis in a patient with drug-induced hypersensitivity syndrome Clin Exp Dermatol 33 2008 287 290
20. T. Shiohara, M. Kurata, Y. Mizukawa, and Y. Kano Recognition of immune reconstitution syndrome necessary for better management of patients with severe drug eruption and those under immunosuppressive therapy Allergol Int 59 2010 333 343
21. R. Leohloenya, and G. Meintjes Dermatologic manifestations of the immune reconstitution inflammatory syndrome Dermatol Clin 24 2006 549 570
22. P. Joly, B. Janela, F. Tetart, S. Rogez, D. Picard, and M. D'Incan Poor benefit/risk balance of intravenous immunoglobulins in DRESS Arch Dermatol 148 2012 543 544
23. R. Takahashi, Y. Kano, Y. Yamazaki, M. Kimishima, Y. Mizukawa, and T. Shiohara Defective regulatory T cells in patients with severe drug eruptions: timing of the dysfunction is associated with the pathological phenotype and outcome J Immunol 182 2009 8071 8079
24. N. Aota, and T. Shiohara Viral connection between drug rashes and autoimmune diseases: how autoimmune responses are generated after resolution of drug rashes Autoimmune Rev 8 2009 488 494
25. M.R. Chen Epstein-Barr virus, the immune system, and associated diseases Front Microbiol 2 2011 5
26. H.H. Niller, H. Wolf, E. Ay, and J. Minarovits Epigenetic dysregulation of Epstein Barr virus latency and development of autoimmune disease Adv Exp Med Biol 711 2011 82 102
27. A. Tselis Epstein-Barr virus cause of multiple sclerosis Curr Opin Rheumatol 24 2012 424 428